Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IPOs In Review: Biopharma Offerings Bounced Back In 2017 As Returns Rose

Executive Summary

With an average return of 33.2% in 2017, the number of biopharma IPOs that launched last year rose to 42 after falling to 30 in 2016 compared with 62 in 2015. Following a rough fourth quarter for biopharma stocks, will the IPO momentum continue in 2018?

Advertisement

Related Content

Finance Watch: Rough US Stock Market Doesn't Stop Biopharma IPOs As Six More Go Public
Finance Watch: The Year's Biggest IPO And A Post-ASH Offering Splash
resTORbio's Age-Related RTI Program Picks Up Further Funding
Finance Watch: NDA-Ready Impact Gets Commitment For Another $90m
IPO Update: New Filings Feed Investor Fervor As Biopharma Stocks Rise
Finance Watch: Lilly Cuts 3,500 Jobs Globally To Drive Growth
Finance Watch VC Edition: Biopharma Venture Investment Rises In Second Quarter
What Could Come After CAR-T? Cue Is Betting On Selective Biologics
Finance Watch: Second Quarter Begins With Solid Base For Biopharma VC, Shaky Ground For Acorda
US IPOs In Review: Relatively Muted Market In 2016 To Continue In 2017

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC100144

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel